Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
JAMA Dermatol ; 160(3): 320-327, 2024 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-38265770

RESUMEN

Importance: Plasma cell orificial mucositis (PCOM) associated with cocaine use is an emerging, rare condition that has become a concern in Spain in recent years. Limited knowledge exists regarding this novel condition. Objectives: To delineate the clinicopathologic characteristics of this emerging entity and establish a novel approach in the differential diagnosis of cocaine-associated lesions. Design, Setting, and Participants: A descriptive, retrospective, multicenter case series of 10 patients diagnosed with cocaine-associated PCOM was conducted in Spain from April 2020 to March 2023. Main Outcomes and Measures: Patient demographic, clinical, histopathologic, and treatment data were collected. Results: A total of 10 patients (6 [60%] male; median [range] age, 45.5 [36-66] years) presenting with exudative ulcerated plaques were identified for this study. The lesions had raised and erythematous edges over the nostril and a median (range) evolution time of 9 (2-24) months. Septal or palate perforations were observed in 4 (40%) of the patients. Biopsies revealed a dense inflammatory infiltrate of plasma cells in the dermis without atypia and with eosinophils. All patients reported recent cocaine use. Three urine tests detected cocaine but found no presence of amphetamines or opiates. Six patients improved with corticosteroid therapy. Up to 60% of patients were lost to follow-up. Conclusions and Relevance: This case series describes the clinicopathologic characteristics of PCOM, an emerging entity associated with cocaine use in Spain, and demonstrates a novel approach in the differential diagnosis of cocaine-associated lesions. To date, cocaine-associated skin lesions have been reported as neutrophilic dermatoses and vasculitis. The appearance of a plasma cell infiltrate changes what has been described in the medical literature so far. PCOM is a benign condition of unknown cause characterized by a proliferative polyclonal plasma cell infiltrate. A comprehensive differential diagnosis workup is required to reach this exclusionary diagnosis. Several irritants have been documented in cases of PCOM, and a hypersensitivity mechanism has been proposed. Since the initial report of cocaine-associated PCOM in Spain, its incidence has experienced a surge in the country. The cause of this phenomenon may be attributed to newly unidentified adulterants. The administration of corticosteroids and discontinuation of cocaine use are the sole treatments that have demonstrated efficacy. Clinicians should be vigilant regarding this emerging condition and conduct inquiries into cocaine use. Additional research is required to clarify the pathophysiology of this emerging condition.


Asunto(s)
Cocaína , Mucositis , Humanos , Masculino , Persona de Mediana Edad , Femenino , Mucositis/patología , Células Plasmáticas/patología , Estudios Retrospectivos , Eritema/patología , Inflamación/patología , Cocaína/efectos adversos
3.
Am J Dermatopathol ; 41(11): 846-850, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30946099

RESUMEN

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma, primary cutaneous CD30 lymphoproliferative disorders (pc CD30 LPD) being the second most prevalent. There is evidence that MF and pc CD30 LPD may coexist and share T-cell clonality, suggesting a common origin. These findings were supported by a T-cell receptor clonality assessment by the polymerase chain reaction coupled with capillary electrophoresis, although results produced by this method may be ambiguous. We describe an otherwise healthy 46-year-old man who developed, over the course of 5 months, a tumor consisting of primary cutaneous anaplastic large cell lymphoma and, subsequently, several papules of lymphomatoid papulosis (LyP). Both lymphomas appeared on a single patch of MF, which had been present on the patient's right buttock for at least 2 years. T-cell receptor clonality of the 3 types of neoplastic lesions and apparently non-involved skin were assessed by a next-generation sequencing-based method. We found that MF, primary cutaneous anaplastic large cell lymphoma and LyP harbored the same top 2 clones. Non-involved skin harbored other T-cell clones. In this patient, these findings suggest that MF, LyP and pc CD30 LPD were different clinicopathological manifestations arising from the neoplastic proliferation of the same T-cell clone.


Asunto(s)
Linfoma Anaplásico de Células Grandes/patología , Papulosis Linfomatoide/patología , Micosis Fungoide/patología , Neoplasias Primarias Múltiples/patología , Neoplasias Cutáneas/patología , Humanos , Antígeno Ki-1 , Masculino , Persona de Mediana Edad , Linfocitos T/patología
4.
Pediatr Dermatol ; 35(6): e398-e399, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30168169

RESUMEN

A female infant presented with an ulcerated lesion on the right side of the vulva. Histopathology showed a suprabasal acantholytic blister with intact papillae protruding into the blister cavity and a few dyskeratotic cells. There were no signs of injury on other locations. Family history was unremarkable. Our patient may have linear Hailey-Hailey disease of the vulva, most likely a case of type 1 mosaic.


Asunto(s)
Pénfigo Familiar Benigno/diagnóstico , Enfermedades de la Vulva/patología , Acantólisis/patología , Femenino , Humanos , Lactante , Mosaicismo , Vulva/patología
5.
Blood ; 127(22): 2672-81, 2016 06 02.
Artículo en Inglés | MEDLINE | ID: mdl-26966089

RESUMEN

The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.


Asunto(s)
Células Dendríticas , Trastornos Histiocíticos Malignos , Histiocitosis de Células de Langerhans , Histiocitosis de Células no Langerhans , Macrófagos , Adulto , Células Dendríticas/clasificación , Células Dendríticas/patología , Femenino , Trastornos Histiocíticos Malignos/clasificación , Trastornos Histiocíticos Malignos/patología , Histiocitosis de Células de Langerhans/clasificación , Histiocitosis de Células de Langerhans/patología , Histiocitosis de Células no Langerhans/clasificación , Histiocitosis de Células no Langerhans/patología , Humanos , Macrófagos/clasificación , Macrófagos/patología , Masculino
6.
Int J Dermatol ; 54(3): 258-70, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25514833

RESUMEN

Immune-mediated diseases frequently affect oral mucosa, which may often be the first site of clinical manifestation. In this review, we describe the most important oral lesions related to inflammatory disorders and present their management and novel therapies. The review is based on an open PubMed literature search from 1980 to 2012 with relevant keywords. Pemphigus vulgaris, oral lichen planus, cicatricial pemphigoid, erythema multiforme, Stevens-Johnson syndrome, systemic lupus erythematosus, Sjögren's syndrome, and linear IgA dermatosis are the immune-mediated diseases with oral manifestations discussed. Etiology is unknown in most of these diseases, but recently some of them have been found to share common genes. Modern treatment of these diseases is based on drugs that interfere along the pathogenic mechanisms instead of the still commonly used palliative measures. However, the immunomodulatory drugs may also cause oral side effects, complicating the clinical picture. Therefore, consulting dental or oral medicine specialists can be necessary in some cases with various immune-mediated diseases.


Asunto(s)
Enfermedades Autoinmunes/diagnóstico , Enfermedades de la Boca/diagnóstico , Enfermedades de la Piel/diagnóstico , Enfermedades Autoinmunes/tratamiento farmacológico , Humanos , Enfermedades de la Boca/tratamiento farmacológico , Enfermedades de la Boca/inmunología , Enfermedades de la Piel/tratamiento farmacológico , Enfermedades de la Piel/inmunología
7.
Am J Dermatopathol ; 33(5): 516-20, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21285861

RESUMEN

The association of multiorgan histiocytosis after acute lymphoblastic leukemias is very rare as most cases are localized forms of Langerhans cell histiocytosis (LCH). We report on an 18-year-old man diagnosed with B-cell acute lymphoblastic leukemia (B-ALL) with p16 deletion (9p21). He was treated with induction chemotherapy using the Spanish PETHEMA group protocol and achieved complete remission. Three months after the diagnosis of B-ALL, he developed a severe multiorgan histiocytosis that is clinically suggestive of LCH but lacked typical immunohistochemical features of LCH and indeterminate cell histiocytosis: CD1a was strongly positive, CD68 and S-100 protein were moderately positive, and langerin was negative. The drugs of the first-line treatment recommended for LCH had been part of the chemotherapy of B-ALL that the patient had received. Therefore, we prescribed the second-line treatment for LCH (cytarabine and 2'-chlorodeoxyadenosine), and he achieved partial remission. The patient died during the aplasia induced by the third cycle of chemotherapy from pneumonia. We could not demonstrate the transdifferentiation of tumoral lymphocytes into histiocytes, using p16 deletion (9p21) as a marker, because these cells did not share the mutation. Neither could we study immunoglobulin-H rearrangement as we had exhausted all the tissue samples. In the medical literature, there are a few reported cases of T-cell acute lymphoblastic leukemia followed by disseminated LCH and just 1 case of B-ALL followed by localized LCH affecting the bones. Therefore, our patient may be the first published case of B-ALL followed by histiocytosis, which had 2 singularities: it was multiorgan and the immunohistochemistry was not typical of LCH.


Asunto(s)
Histiocitosis/complicaciones , Histiocitosis/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras B/complicaciones , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Resultado Fatal , Histiocitosis/tratamiento farmacológico , Humanos , Inmunohistoquímica , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras B/tratamiento farmacológico
8.
Cient. dent. (Ed. impr.) ; 2(1): 7-9, ene.-abr. 2005. ilus
Artículo en Español | IBECS | ID: ibc-87473

RESUMEN

La piodermitis-pioestomatitis vegetante es un trastorno raro y benigno caracterizado por una erupción pustular en la mucosa oral acompañada de placas vegetantes en ingles y pliegues axilares. Su asociación con la enfermedad intestinal inflamatoria está bien establecida. Se presenta el caso de un paciente con colitis ulcerosa que presentaba una placa anular vegetante en la región inguinal izquierda de dos meses de evolución. En la exploración oral presentaba una mucosa eritematosa con múltiples pústulas que afectaban la mucosa labial y gingival. En el estudio histopatológico se observaba hiperplasia epidérmica y un infiltrado inflamatorio compuesto fundamentalmente por neutrófilos y eosinófilos agrupados formando microabscesos dentro de la epidermis y con configuración en banda en la dermis superior. Los resultados de la inmunofluorescencia directa e indirecta fueron negativos. Se discute el diagnóstico diferencial entre piodermitis-pioestomatitis vegetante y pénfigo vegetante (AU)


Pyodermatitis-pyostomatitis vegetans is a benign, rare disorder characterized by a pustular eruption in the oral mucosa and vegetating plaques involving the groin and axillary folds. Its association with inflammatory bowel disease is well established. We report a patient with ulcerative colitis who manifested a vegetating annular plaque in the left inguinal region of 2 months’ duration. Oral examination disclosed an erythematous mucosa with multiple painful pustules involving the labial and gingival mucosa. Histopathologic study demonstrated epidermal hyperplasia and an inflammatory infiltrate composed mostly of neutrophils and eosinophils, grouped into microabscesses within the epidermis and with a band-like configuration in the upper dermis. Results of direct and indirect immunofluorescence studies were negative. We discuss the differential diagnosis between pyodermatitis-pyostomatitis vegetans and pemphigus vegetans (AU)


Asunto(s)
Humanos , Enfermedades de la Boca/patología , Estomatitis/patología , Piodermia/patología , Técnica del Anticuerpo Fluorescente Directa , Diagnóstico Diferencial
9.
Actas dermo-sifiliogr. (Ed. impr.) ; 93(7): 448-450, ago. 2002. ilus
Artículo en Es | IBECS | ID: ibc-12791

RESUMEN

El lentigo en 'mancha de tinta' se caracteriza clínicamente por su color negro y por sus bordes marcadamente irregulares, que recuerdan a una mancha de tinta china sobre la piel. Es una lesión pigmentada de reciente descripción y poco conocida, que puede originar problemas de diagnóstico diferencial, tanto clínico como histopatológico. Histopatológicamente consiste en una hiperpigmentación del extremo inferior de las crestas epidérmicas, con escaso pigmento melánico en la epidermis entre crestas. No se observa proliferación de melanocitos. Se trata de una lesión benigna y sin capacidad de malignizarse (AU)


Asunto(s)
Adulto , Anciano , Femenino , Masculino , Persona de Mediana Edad , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/etiología , Melanoma/diagnóstico , Lentigo/diagnóstico , Lentigo/etiología , Lentigo/cirugía , Diagnóstico Diferencial , Melanocitos/patología , Carcinoma Basocelular/complicaciones , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/cirugía , Lentigo/patología , Piel/patología
10.
Actas dermo-sifiliogr. (Ed. impr.) ; 93(6): 393-396, jun. 2002. ilus
Artículo en Es | IBECS | ID: ibc-12120

RESUMEN

El miofibroma cutáneo es una entidad infrecuente, de la que recientemente se ha descrito la variante del adulto, que hoy día se considera independiente de la infantil. Clínicamente se manifiesta como un nódulo solitario, de consistencia firme y a menudo multilobulado. La lesión presenta una histopatología característica en la que se mezclan áreas 'miofibroblásticas' y hemangiopericitoiden. Presentamos el caso de un hombre de 73 años con un nódulo multilobulado localizado en muslo derecho de 10 años de evolución. La lesión era dolorosa a la manipulación. Se realizó una exéresis y el estudio histopatológico demostró un miofibroma cutáneo, con la particularidad de presentar algunos nódulos a distancia de la lesión principal. No ha presentado recidiva tras 2 años de seguimiento. Realizamos una revisión de esta entidad (AU)


Asunto(s)
Masculino , Persona de Mediana Edad , Humanos , Inmunohistoquímica/métodos , Inmunohistoquímica/tendencias , Leiomioma/diagnóstico , Leiomioma/cirugía , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Pronóstico , Piel/patología , Leiomioma/clasificación , Leiomioma/fisiopatología , Músculo Liso/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...